Discover
ROIV
Roivant Sciences Ltd.
35.03
2 x 32.43
2 x 38.09
bid
ask
-
0.36
1.02%
2 @ 04:00 PM
35.52 +0.49 (1.40%)
| Ytd | 61.43% | |
| 1y | 219.33% |
34.81
day range
35.76
10.71
52 week range
35.90
| Open | 35.39 | Prev Close | 35.39 | Low | 34.81 | High | 35.76 | Mkt Cap | 25.20B |
| Vol | 4.37M | Avg Vol | 5.88M | EPS | -0.54 | P/E | N/A | Forward P/E | -22.70 |
| Beta | 1.14 | Short Ratio | 5.12 | Inst. Own | 75.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-10 | 50-d Avg | 29.90 | 200-d Avg | 24.38 | 1yr Est | 39.04 |
| Income Statement | |||
| Total Revenue | 2.52M | ||
| Revenues (USD) | 2.52M | ||
| Cost of Revenue | 320.00K | ||
| Gross Profit | 2.20M | ||
| Operating Expenses | -413.04M | ||
| Research and Development Expense | 198.95M | ||
| Selling, General and Administrative Expense | 158.25M | ||
| Operating Income | 415.24M | ||
| Income Tax Expense | 98.35M | ||
| Net Income | 302.99M | ||
| Net Income Common Stock | 302.99M | ||
| Net Income Common Stock (USD) | 302.99M | ||
| Consolidated Income | 355.74M | ||
| Net Income to Non-Controlling Interests | 52.75M | ||
| Earnings per Basic Share | 0.45 | ||
| Earnings per Basic Share (USD) | 0.45 | ||
| Earnings per Diluted Share | 0.34 | ||
| Earning Before Interest & Taxes (EBIT) | 401.35M | ||
| Earning Before Interest & Taxes (USD) | 401.35M | ||
| Weighted Average Shares | 717.30M | ||
| Weighted Average Shares Diluted | 717.30M | ||
| Balance Sheet | |||
| Cash and Equivalents | 1.42B | ||
| Cash and Equivalents (USD) | 1.42B | ||
| Investments | 3.28B | ||
| Investments Current | 2.87B | ||
| Investments Non-Current | 407.99M | ||
| Trade and Non-Trade Receivables | 770.24M | ||
| Current Assets | 5.17B | ||
| Property, Plant & Equipment Net | 92.40M | ||
| Total Assets | 5.71B | ||
| Debt Current | 11.15M | ||
| Total Debt | 107.44M | ||
| Current Liabilities | 281.24M | ||
| Debt Non-Current | 96.29M | ||
| Total Liabilities | 416.28M | ||
| Accumulated Retained Earnings (Deficit) | -501.81M | ||
| Accumulated Other Comprehensive Income | 4.36M | ||
| Shareholders Equity | 4.53B | ||
| Shareholders Equity (USD) | 4.53B | ||
| Assets Non-Current | 541.30M | ||
| Total Debt (USD) | 107.44M | ||
| Liabilities Non-Current | 135.03M | ||
| Trade and Non-Trade Payables | 18.00M | ||
| Tax Liabilities | 84.36M | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.50M | ||
| Net Cash Flow from Financing | -68.78M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | -57.79M | ||
| Capital Expenditure | -1.26M | ||
| Net Cash Flow - Business Acquisitions and Disposals | -4.42M | ||
| Issuance (Purchase) of Equity Shares | -109.81M | ||
| Net Cash Flow from Investing | 173.49M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | 179.17M | ||
| Net Cash Flow from Operations | -163.82M | ||
| Effect of Exchange Rate Changes on Cash | 1.32M | ||
| Share Based Compensation | 77.17M | ||